Clinical Trial Update: E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events [Phase 3]

View source ↗

Summary

Phase 3 trial update for cinacalcet hydrochloride (E.V.O.L.V.E. Trial) assessing its impact on cardiovascular events in secondary hyperparathyroidism and chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Cinacalcet hydrochloride (cinacalcet)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-01-22